← Browse by Condition
Medical Condition

alcohol use disorder

Total Trials
19
Recruiting Now
19
Trial Phases
Phase 2, Phase 4, Phase 3

ClinicalMetric tracks all active clinical trials for alcohol use disorder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — alcohol use disorder Clinical Trials

How many clinical trials are currently recruiting for alcohol use disorder?
ClinicalMetric currently tracks 19 actively recruiting clinical trials for alcohol use disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 19. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for alcohol use disorder?
alcohol use disorder research spans Phase 2 (4 trials), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a alcohol use disorder clinical trial?
Eligibility criteria for alcohol use disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
4
Phase 3
1
Phase 4
1
Top Sponsors
University of Cambridge 1 trial
Jessica Weafer 1 trial
Boston University 1 trial
Anders Fink-Jensen, MD, DMSci 1 trial
Clemson University 1 trial

Recruiting Clinical Trials

NCT07341230
Recruiting
Deep Brain Stimulation to Understand and Treat Addiction
Enrollment
9 pts
Location
United Kingdom
Sponsor
University of Cambridge
View Trial →
NCT04929288
Recruiting
Neural and Hormonal Influences on Sex Differences in Risk for AUD
Enrollment
100 pts
Location
United States
Sponsor
Jessica Weafer
View Trial →
NCT07232641
Recruiting
Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic
Enrollment
185,810 pts
Location
United States
Sponsor
Boston University
View Trial →
NCT06939088 Phase 2
Recruiting
Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
Enrollment
108 pts
Location
Denmark
Sponsor
Anders Fink-Jensen, MD, DMSci
View Trial →
NCT06479681
Recruiting
A Peer Recovery Coaching Intervention for Hospitalized Alcohol Use Disorder Patients
Enrollment
750 pts
Location
United States
Sponsor
Clemson University
View Trial →
NCT07925281
Recruiting
Emotional Reactivity in Severe Alcohol Use Disorder and Major Depressive Disorder Using Eye-tracking, Physiological, and Interoceptive Measures (ERAD)
Enrollment
280 pts
Location
Belgium
Sponsor
Université Catholique de Louva...
View Trial →
NCT06415721
Recruiting
Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
Enrollment
40 pts
Location
United States
Sponsor
VA Palo Alto Health Care Syste...
View Trial →
NCT06269627 Phase 4
Recruiting
Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder
Enrollment
48 pts
Location
United States
Sponsor
National Institute on Alcohol ...
View Trial →
NCT03667846 Phase 2
Recruiting
Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD
Enrollment
150 pts
Location
United States
Sponsor
NYU Langone Health
View Trial →
NCT05997212
Recruiting
Effect of Repetitive TMS on Executive Function in Alcohol Use Disorder
Enrollment
44 pts
Location
Mexico
Sponsor
Universidad Nacional Autonoma ...
View Trial →
NCT05178069 Phase 2
Recruiting
LGG Supplementation in Patients With AUD and ALD
Enrollment
60 pts
Location
United States
Sponsor
University of Louisville
View Trial →
NCT05827159 Phase 3
Recruiting
Emergency Department-Initiated Medications for Alcohol Use Disorder
Enrollment
240 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT06405607 Phase 2
Recruiting
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
Enrollment
80 pts
Location
United States
Sponsor
University of Iowa
View Trial →
NCT06005298
Recruiting
Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention
Enrollment
120 pts
Location
United States
Sponsor
Shirish S Barve
View Trial →
NCT02037867
Recruiting
Nottingham Community Liver Biomarkers Cohort
Enrollment
2,000 pts
Location
United Kingdom
Sponsor
University of Nottingham
View Trial →
NCT07713251
Recruiting
Supporting Adolescent Alcohol Treatment With Computer-Based ('Path180') Skills Training
Enrollment
112 pts
Location
United States
Sponsor
Brown University
View Trial →
NCT06084520
Recruiting
Translation and Validation of the COMM and ASI-SR
Enrollment
400 pts
Location
Sweden
Sponsor
Uppsala University
View Trial →
NCT06139224
Recruiting
Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection
Enrollment
40 pts
Location
United States
Sponsor
Rush University Medical Center
View Trial →
NCT05778734
Recruiting
StuDy AimED at Increasing AlCohol AbsTinEnce
Enrollment
104 pts
Location
United States
Sponsor
University of Illinois Chicago
View Trial →

Related Conditions

opioid use disorder (2) alcohol dependence (2) alcoholism (2) alcohol abuse (2) substance use disorders (1) alcohol abuse dependence (1) schizophrenia disorders (1) schizophrenia and disorders with psychotic features (1) schizophrenia and schizophrenia spectrum psychosis (1) schizophrenia (1) major depressive disorder mdd (1) drinking behavior (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology